Kodak and R2 Technologies have entered into a joint marketing agreement to bundle each other’s products—Kodak’s MIN-R 2000 mammography screen-film system and R2’s ImageChecker system—for sale to Novation and the University
Kodak and R2 Technologies have entered into a joint marketing agreement to bundle each other’s products-Kodak’s MIN-R 2000 mammography screen-film system and R2’s ImageChecker system-for sale to Novation and the University HealthSystem Consortium. Kodak and R2 each already has a sole source agreement with the two group purchasing organizations. ImageChecker is a computer-aided detection system designed to digitize, analyze, and flag suspicious areas on mammograms. The Kodak MIN-R 2000 yields greater resolution, more detail, and higher contrast than any other Kodak mammography screen-film system. The joint agreement is designed to enable Voluntary Hospital Association and UHC members to easily avail themselves of Kodak’s and R2’s products. Novation is the supply company for VHA; UHC represents more than 2300 healthcare organizations.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.